Kenya rolls out free lenacapavir HIV shots

Kenya just kicked off a game-changer in HIV prevention with lenacapavir, a six-month injection that could drastically alter the fight against HIV.

Kenya launches lenacapavir for HIV prevention

• Kenya is one of the first countries to offer lenacapavir.
• The long-acting injection will be available for free to eligible patients.
• It’s a major step in tackling Kenya's HIV crisis, with 1.4 million affected.

Lenacapavir hits the market after global buzz

• Science magazine named lenacapavir ‘Breakthrough of the Year’ in 2024.
• The injection is given subcutaneously every six months.
• Pregnant and breastfeeding women can safely use lenacapavir.

Kenya and global partners roll out the drug

• 21,000 doses were delivered in the first batch, with more to come.
• Gilead Sciences and the Global Fund helped secure the drug.
• The U.S. is contributing 25,000 more doses for early roll-out.

Impact on Africa’s HIV prevention efforts

• South Africa, Zambia, Eswatini, and Zimbabwe have also started using lenacapavir.
• Kenya is pushing to protect its young population, especially those aged 15-24.
• The government is tracking side effects to ensure safety.